2024 Global Immunohematology NAT Screening US

2024 Global Immunohematology and NAT Screening: US, Europe, Japan--Transfusion Medicine Analyzers and Reagents--Supplier Shares and Strategies, Technology and Instrumentation Review, Emerging Opportunities

This new seven-country strategic analysis was prepared by in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. 

Rationale

During the next five years, the global blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology.

The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.

Strategic Recommendations

- New product development opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.

Worldwide Market Overview

- Estimates of facilities performing blood banking tests, by country.
- Test volume and sales projections by country.

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

The report explores future marketing and technological trends in the US, Europe and Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin,
Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s),
Antiglobulin (Direct, C3 + IgG, IgG,  C3),
Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus,
Hepatitis (HAV NAT, HBV NAT, HBs Ag, ; 
Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT,
Syphilis, West Nile Virus NAT.

Sales and Market Share Analysis
Sales and market share estimates of leading
suppliers of blood banking of reagents
and instruments, by country and individual
product.

Competitive Assessments

Strategic assessments of major suppliers and
emerging market entrants, including their sales,
product portfolios, marketing tactics, and new
products in R&D.

Market Segmentation Analysis

- Comprehensive market segmentation
analysis, including review of the market
dynamics, trends, structure, size, growth,
and key suppliers by country.

- Test volume and sales forecasts for over 40
blood banking tests, including NAT,
by country and market segment:

- Blood Centers
- Plasma Fractionation Facilities
- Hospitals
- Commercial/Private Laboratories
- Military Blood Banks

Current and Emerging Products

- Analysis of current and emerging blood banking tests.
- Review of automated and semi-automated
analyzers, including their operating
characteristics, features, and selling prices.

Technology Review

- Assessment of current and emerging
technologies, and their potential applications
for the blood banking market.

- Comprehensive lists of companies developing
or marketing new technologies and products by test.

Contains 775 pages and 227 tables

" This new seven-country strategic analysis was prepared by in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies.

I. Introduction
II. Worldwide Market Overview
1. Business Environment
2. Market Structure
3. Market Size and Growth
III. Major Product Development Opportunities
A. Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
VI. Worldwide Technology and Market Overview
A. Major Blood Typing, Grouping and Infectious
Disease Screening Tests
1. Blood Typing and Grouping Tests
a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test

f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups
2. Infectious Disease Screening Tests
a. AIDS/HIV
- Background
- Diagnostic Tests
Enzyme Immunoassay
Viral Load/Drug Resistance Testing
Genotype and Phenotype Testing
- Blood Banking Considerations
b. Hepatitis Markers
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis D (Delta Hepatitis)
- Hepatitis E
- Hepatitis G
- Vaccines and Drugs
c. Cytomegalovirus
- Background
- Diagnostic Tests
- Vaccines and Drugs
d. Syphilis
- Background
- Diagnostic Tests
- Vaccines and Drugs
e. West Nile Virus
- Background
- Clinical Syndromes
- Diagnostic Tests
- Vaccines and Drugs
f. Parvovirus B19
- Microbiology
- Epidemiology
- Clinical Syndromes
- Diagnostic Test
- Vaccines and Drugs

g. Creutzfeldt-Jakobs Disease
- Background
- Transmission
- Diagnostic Tests
- Vaccines and Drugs
h. Malaria
i. Chagas Disease
j. Babesiosis
3. Pathogen Reduction
4. Leukocyte Reduction
- Background
- Methods
B. Instrumentation Review: Operating Characteristics,
Features and Selling Prices of Leading Blood Typing,
Grouping and Infectious Disease Screening Automated
and Semiautomated Analyzers
C. Major Blood Banking Technologies
and Their Potential Applications
1. Molecular Diagnostics
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
4. Microtitration Plates
5. IT and Automation
6. Lasers
7. Robotics
8. Synthetic Red Cell Substitutes
9. Genetically Engineered Blood Components
10. Blood Preservation
11. Autologous Blood Transfusion/Freezing
VII. France Blood Banking Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, by Market Segment,
Major Supplier Sales and Market Shares

VIII. Germany Blood Banking Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, by Market Segment,
Major Supplier Sales and Market Shares
IX. Italy Blood Banking Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, by Market Segment,
Major Supplier Sales and Market Shares
X. Japan Blood Banking Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, by Market Segment,
Major Supplier Sales and Market Shares
XI. Spain Blood Banking Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, by Market Segment,
Major Supplier Sales and Market Shares
XII. U.K. Blood Banking Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, by Market Segment,
Major Supplier Sales and Market Shares

XIII. U.S.A. Blood Banking Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, by Market Segment,
Major Supplier Sales and Market Shares
XIV. Competitive Assessments
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Diagast
DiaSorin
Fujirebio
Grifols
Hologic
LabCorp
Proteome Sciences
Quest Diagnostics
QuidelOrtho
Roche
Siemens Healthineers
Tecan
Thermo Fisher
Werfen/Immucor

List Of Tables

Tumor Marker Classification
Major Companies Developing or Marketing
ACTH Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
Beta-2 Microglobulin Tests
Major Companies Developing or Marketing
CA 15-3/27.29 Tests
Major Companies Developing or Marketing
CA 19-9 Tests
Major Companies Developing or Marketing
CA 125 Tests
Major Companies Developing or Marketing
Calcitonin Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Estrogen Receptor Tests
Major Companies Developing or Marketing
Progesterone Receptor Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
Gastrin Tests

Major Companies Developing or Marketing
HCG Tests

Major Companies Developing or Marketing
Insulin Tests

Major Companies Developing or Marketing
NSE Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
PAP Smear/HPV Tests
Major Companies Developing or Marketing
PAP Tests
Major Companies Developing or Marketing
PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or Marketing
Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis

Immunohistochemical Stains Potential
Applications in Cancer Diagnosis
Executive Summary Table: France, Total Cancer
Diagnostic Test Volume and Sales Forecast
by Market Segment
France, Estimated Cancer Death Rates
Per 100,000 Population
France, Laboratories Performing Tumor
Marker Tests by Market Segment
France, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
France, Commercial/Private Laboratories
Performing Tumor Markers by Annual Test Volume
France, Total Tumor Marker Test Volume
Forecast by Market Segment
France, All Market Segments Major Tumor
Marker Test Volume Forecast
France, Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
France, Commercial/Private Laboratories
Marker Test Volume Forecast
France, Total Tumor Marker Sales Major Tumor
Forecast by Market Segment
France, All Market Segments Major Tumor
Marker Sales Forecast by Test
France, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test

France, Commercial/Private Laboratories Cancer
Diagnostics Market Forecast by Test
France, ACTH Test Volume and Diagnostics Sales
Forecast by Market Segment
France, AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecast by Market Segment

France, CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecast by Market Segment
France, CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market
France, CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
France, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Colon-Specific Antigen Test Volume
And Diagnostics Sales Forecast by Market Segment
France, Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market Segment


France, Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Ferritin Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Gastrin Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, HCG Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Insulin Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Interferons Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Interleukins Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Lymphocyte Subtyping Test Volume
And Diagnostics Sales Forecast by Market
Segment
France, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Nucleolar Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Occult Blood Test Volume and
Diagnostics Sales Forecast by Market
Segment

France, Oncogenes Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
France, PAP Smear Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Parathyroid Hormone Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Progesterone Receptor Test Volume
And Diagnostics Sales Forecast by Market
Segment

France, PAP Test Volume and Diagnostics Sales
Forecast by Market Segment
France, PSA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, S-100 Protein Test Volume and Sales
Diagnostics Sales Forecast by Market
Segment
France, Serotonin Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market
Segment



France, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
France, TDT Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Thymidine Kinase Test Volume
And Diagnostics Sales Forecast by
Market Segment
France, Thyroglobulin Test Volume and
Diagnostics Sales Forecast by Market
Segment
France, TPA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Total Tumor Marker Sales
By Major Suppliers
France, AFP Testing Market Diagnostics
Sales by Major Supplier
France, CA 15-3 Testing Market Diagnostics
Sales by Major Supplier
France, CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
France, CA 125 Testing Market Diagnostics
Sales by Major Supplier
France, CEA Testing Market Diagnostics
Sales by Major Supplier
France, NSE Testing Market Diagnostics
Sales by Major Supplier


France, PAP Testing Market Diagnostics
Sales by Major Supplier
France, PSA Testing Market Diagnostics
Sales by Major Supplier
Executive Summary Table: Germany, Total
Tumor Marker Test Volume and Sales Forecast
By Market Segment

Germany, Estimated Cancer Death Rates
Per 100,000 Population
Germany, Laboratories Performing Tumor
Marker Tests by Market Segment
Germany, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Germany, Commercial/Private Laboratories
Performing Tumor Markers by Annual
Test Volume
Germany, Total Tumor Marker Test Volume
Forecast by Market Segment
Germany, All Market Segments, Major Tumor
Marker Test Volume Forecast
Germany, Hospital Laboratories, Major
Tumor Marker Test Volume Forecast by Test

Germany, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
Germany, Physician Offices/Group
Practices Major Tumor Marker
Test Volume Forecast
Germany, Total Tumor Marker Sales
Forecast by Market Segment
Germany, All Market Segments Major Tumor
Marker Sales Forecast by Test
Germany, Hospital Laboratories, Major Tumor
Marker Sales Forecast by Test
Germany, Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
Germany, Physician Offices/Group Practices
Major Tumor Marker Sales Forecast by Test
Germany, ACTH Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, AFP Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Beta-2 Microglobulin Test Volume
And Diagnostics Sales Forecast by Market Segment
Germany, CA-15-3/27.29 Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, CA-19 Test Volume and Diagnostics
Sales Forecast by Market Segment

Germany, CA 125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Calcitonin Test Volume
And Diagnostic Sales Forecast by Market Segment
Germany, Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Germany, Chromogranin Test Volume
And Diagnostics Sales Forecast by Market Segment
Germany, Colon-Specific Antigen Test Volume
And Diagnostics Sales Forecast by Market Segment
Germany, Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, HCG, Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment

Germany, Interferons Test Volume and
Diagnostics Sales Forecast by Market Segment

Germany, Interleukins Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Lymphocyte Subtyping Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Occult Blood Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Oncogenes Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
Germany, Pap Smear Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Parathyroid Hormone Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Progesterone Receptor Test Volume
And Diagnostics Sales Forecast by Market Segment
Germany, PAP Test Volume and Diagnostics
Sales Forecast by Market Segment


Germany, PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, S-100 Protein Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Serotonin Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales Forecast
By Market Segment
Germany, TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Thymidine Kinase Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, Thyroglobulin Test Volume and
Diagnostics Sales Forecast by Market Segment
Germany, TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Total Tumor Marker Sales
By Major Supplier


Germany, AFP Testing Market Diagnostics
Sales by Major Supplier
Germany CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Germany CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
Germany, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Germany, CEA Testing Market Diagnostics
Sales by Major Supplier
Germany, PSA Testing Market Diagnostics
Sales by Major Supplier
Executive Summary Table: Italy, Total Tumor
Marker Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Estimated Cancer Death Rates
Per 100,000 Population
Italy, Laboratories Performing Tumor
Marker Tests by Market Segment
Italy, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Italy, Commercial/Private Laboratories
Performing Tumor Markers by Annual
Test Volume

Italy, Total Tumor Marker Test Volume
Forecast by Market Segment
Italy, All Market Segments Major Cancer
Diagnostic Test Volume Forecast
Italy, Hospital Laboratories Major Tumor
Marker Test Volume Forecast
Italy, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
Italy, Total Tumor Marker Test Market
Forecast by Market Segment
Italy, All Market Segments Major Tumor
Marker Sales Forecast by Test
Italy, Hospital Laboratories Major
Tumor Marker Forecast by Test
Italy, Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
Italy, ACTH Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, AFP Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Beta-2 Microglobulin Test Volume
And Diagnostics Sales Forecast by Market Segment
Italy, CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecast by Market Segment

Italy, CA-19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, CA 125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Chromogranin Test Volume
And Diagnostics Sales Forecast by Market Segment
Italy, Colon Specific Antigen Test Volume
And Diagnostics Sales Forecast by Market Segment
Italy, Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market Segment
Italy, Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market Segment
Italy, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment

Italy, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment

Italy, HCG Test Volume and Diagnostics
Sales Forecast by Market Segment

Italy, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment


Italy, Lymphocyte Subtyping Test Volume
And Diagnostics Sales Forecast by Market
Segment

Italy, NSE Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Occult Blood Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Oncogenes Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Pancreatic Oncofetal Antigen Test
Volume and Diagnostics Sales Forecast
By Market Segment
Italy, PAP Smear Test Volume and
Diagnostics Sales Forecast by Market Segment
Italy, Parathyroid Hormone Test Volume and
Diagnostics Sales Forecast by Market Segment
Italy, Progesterone Receptor Test Volume and
Diagnostics Sales Forecast by Market Segment
Italy, PAP Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, PSA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, S-100 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Serotonin Test Volume and
Diagnostics Sales Forecast by Market Segment

Italy, Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market Segment
Italy, Squamous Cell Carcinoma Antigen Test
Volume and Diagnostics Sales Forecast
By Market Segment
Italy, TDT Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Thymidine Kinase Test Volume and
Diagnostics Sales Forecast by Market Segment
Italy, Thyroglobulin Test Volume and
Diagnostics Sales Forecast by Market Segment
Italy, TPA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Total Tumor Markers
Sales by Major Suppliers
Italy, AFP Testing Market Diagnostics
Sales by Major Supplier
Italy, CEA Testing Market Diagnostics
Sales by Major Supplier
Italy, PSA Testing Market Diagnostics
Sales by Major Supplier



Executive Summary Table: Japan, Total Tumor
Marker Test Volume and Sales Forecast by
Market Segment
Japan, Estimated Cancer Death Rates
Per 100,000 Population
Japan, Laboratories Performing Tumor
Marker Tests by Market Segment
Japan, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Japan, Commercial/Private Laboratories
Performing Tumor Marker Tests
By Annual Test Volume
Japan, Total Tumor Marker Testing Volume
Forecast by Market Segment
Japan, All Market Segments Major Tumor
Marker Test Volume Forecast
Japan, Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
Japan, Commercial/Private Laboratories Major
Tumor Marker Test Volume Forecast
Japan, Total Tumor Marker Sales
Forecast by Market Segment
Japan, All Market Segments Major Tumor
Marker Sales Forecast by Test
Japan, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
Japan, Commercial/Private Laboratories Major
Tumor Marker Sales Forecast by Test

Japan, ACTH Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, CEA Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Chromogranin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Colon-Specific Antigen Test Volume
And Diagnostics Sales Forecast by Market
Segment

Japan, Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Ferritin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Gastrin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, HCG Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Interferons Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Interleukins Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Lymphocyte Subtyping Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, NSE Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, Nucleolar Test Volume and
Diagnostics Sales Forecast by Market
Segment

Japan, Occult Blood Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Oncogenes Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, PAP Smear Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Progesterone Receptor
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, PAP Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, PSA Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, S-100 Protein Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Serotonin Test Volume and
Diagnostics Sales Forecast by Market
Segment

Japan, Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market
Segment
Japan, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Thyroglobulin
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, TPA, Test Volume and Diagnostics
Sales Forecast by Market Segment
`Japan, Total Tumor Marker
Sales by Major Suppliers
Japan, AFP Testing Market Diagnostics
Sales by Major Supplier
Japan, CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Japan, CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
Japan, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Japan, Calcitonin Testing Market Diagnostics
Sales by Major Supplier

Japan, PAP Testing Market Diagnostics
Sales by Major Supplier
Japan, PSA Testing Market Diagnostics
Sales by Major Supplier
Executive Summary Table: Spain, Total
Tumor Marker Test Volume and Sales
Forecast by Market Segment
Spain, Estimated Cancer Death Rates
Per 100,000 Population
Spain, Laboratories Performing Tumor
Marker Tests by Market Segment
Spain, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Spain, Commercial/Private Laboratories
Performing Tumor Markers by
Annual Test Volume
Spain, Total Tumor Marker Test Volume
Forecast by Market Segment
Spain, All Market Segment Major Cancer
Diagnostic Test Volume Forecast
Spain, Hospital Laboratories Major Cancer
Diagnostic Test Volume Forecast by Test
Spain, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
Spain, Total Tumor Marker Sales
Forecast by Market Segment

Spain, All Market Segments Major Tumor
Marker Sales Forecast by Test
Spain, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
Spain, Commercial/Private Laboratories Major
Tumor Marker Sales Forecast by Test
Spain, AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
Spain, Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecast by Market Segment
Spain, CA 15-3 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Spain, Colon-Specific Antigen Test Volume and
Diagnostics Sales Forecast by Market Segment
Spain, Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market Segment
Spain, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment

Spain, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Lymphocyte Subtyping
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Occult Blood Test Volume and
Diagnostics Sales Forecast by Market
Segment
Spain, Oncogenes Test Volume and
Diagnostics Sales Forecast by Market
Segment

Spain, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, PAP Smear Test Volume and
Diagnostics Sales Forecast by Market
Segment
Spain, Parathyroid Hormone Test Volume
And Diagnostics Sales Forecast by Market
Segment
Spain, Progesterone Receptor
Test Volume and Diagnostics Sales Forecast
by Market Segment

Spain, PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, S-100 Protein Test Volume
And Diagnostics Sales Forecast by Market
Segment
Spain, Serotonin Test Volume and
Diagnostics Sales Forecast by Market
Segment
Spain, Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market
Segment
Spain, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain, TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Thyroglobulin
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Total Tumor Marker Sales by Major Suppliers

Spain, AFP Testing Market Diagnostics
Sales by Major Supplier
Spain, CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Spain, 19-9 Testing Market Diagnostics
Sales by Major Supplier
Spain, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Spain, CEA Testing Market Diagnostics
Sales by Major Supplier
Spain, PSA Testing Market Diagnostics
Sales by Major Supplier
Executive Summary Table: U.K., Total
Tumor Marker Test Volume and Sales
Forecast by Market Segment
U.K., Estimated Cancer Death Rates
Per 100,000 Population
U.K., Laboratories Performing Tumor
Marker Tests by Market Segment
U.K., Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
U.K., Commercial/Private Laboratories
Performing Tumor Marker Tests by
Annual Test Volume
U.K., Total Tumor Marker Testing Volume
Forecast by Market Segment
U.K., All Market Segments Major
Tumor Marker Test Volume Forecast

U.K., Hospital Laboratories Major
Tumor Marker Test Volume Forecast
by Test
U.K., Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
U.K., Total Tumor Marker Sales
Forecast by Market Segment

U.K., All Market Segments Major
Tumor Marker Sales Forecast by Test
U.K., Hospital Laboratories Major
Tumor Marker Sales Forecast by Test
U.K., Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test

U.K., ACTH Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K., AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K., Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecast by Market Segment
U.K., CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecast by Market Segment
U.K., CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment

U.K., Calcitonin Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., CEA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Chromogranin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Colon-Specific Antigen Test Volume
And Diagnostics Sales by Market
Segment
U.K., Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., Ferritin Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Lymphocyte Subtyping Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., NSE Test Volume and Diagnostics
Sales Forecast by Market Segment

U.K., Occult Blood Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., Oncogenes Test Volume and
Diagnostics Sales Forecast by Market
Segment
U.K., Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PAP Smear Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Progesterone Receptor
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., S-100 Protein Test Volume and
Diagnostics Sales Forecast by Market Segment
U.K., Serotonin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Sialic Acid Test Volume and
Diagnostics Sales Forecast by Market Segment

U.K., Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Thyroglobulin
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., TPA Test Volume and Diagnostics
Sales Forecast by Market Segment

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available